Advances in the Research and Application of Exosomes in Disease Detection and Diagnosis
Exosomes are vesicles secreted by cells that are widely present in various bodily fluids such as blood, urine, saliva, milk, and have a particle size ranging from 30 to 150 nanometers.
September 3, 2025
by Xiaonisha
Golden Pen Award | Research Progress on the Application of Exosomes in Drug Delivery
Exosomes are specific membrane vesicles secreted by various types of cells under normal or pathological conditions, playing a vital role in intercellular communication and exchange of information.
September 2, 2025
by Xiaonisha
Research Progress on the Biological Activities and Mechanisms of Action of Sulforaphane
Sulforaphane, also known as sulforaphane glucosinolate, is an isothiocyanate compound produced by the hydrolysis of glucosinolates under the action of endogenous myrosinase.
August 28, 2025
by Xiaonisha
Golden Pen Award | The Current Status of Application of Biomembrane Nanocarrier Drug Delivery Systems in Tumor Immunotherapy
In recent years, the excellent biocompatibility, modifiability, and low immunogenicity of biomembrane nanosystems have significantly advanced the development of tumor immunotherapy.
August 27, 2025
by Xiaonisha
Advances in Research on Nrf2 Activators Based on Natural Products and Their Derivatives (Part II)
The Keap1-Nrf2-ARE signaling pathway is one of the critical mechanisms for cellular defense against oxidative stress damage.
August 21, 2025
by Xiaonisha
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies
Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash.
August 2, 2025
by ACN Newswire
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ
Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate JSKN003 has been granted Orphan Drug Designation by the FDA for the treatment of gastric cancer and gastroesophageal junction cancer (GC/GEJ).
July 29, 2025
by PR Newswire
Research Progress on the Target GDF15 Signaling Pathway and Related Drugs
Growth differentiation factor 15 (GDF15), identified and discovered from activated macrophage lineage clones, functions as an autocrine regulatory molecule in macrophages and serves as an endocrine hormone.
July 25, 2025
by Xiaonisha
Research Progress on Therapeutic Human Papillomavirus (HPV) Vaccines
Currently, the research and development technology for prophylactic human papillomavirus (HPV) vaccines is becoming increasingly mature (related reading: "Current Status of Research and Application of Prophylactic Human Papillomavirus (HPV) Vaccines").
July 23, 2025
by Xiaomichong
Current Status of Research and Application of Preventive Human Papillomavirus (HPV) Vaccines
In recent years, the topic of "HPV vaccine" has maintained a high level of attention, with netizens complaining about the difficulty of obtaining a vaccine.
July 23, 2025
by Xiaomichong
Research Progress on the Bioactivities and Pharmacological Mechanisms of Naringin
Naringin, also known as heteroside, citrus glycoside, and neohesperidin, has the chemical name of 4,5,7-trihydroxyflavanone-7-rhamnoside.
July 23, 2025
by Xiaomichong
AXA and Prosper Health introduce pioneering dedicated cancer case management service in Greater Bay Area[1]
AXA Hong Kong and Macau partners with Prosper Health to launch the Greater Bay Area Cancer Medical Concierge Service Network for eligible customers, integrating resources to meet cross - border medical demands.
January 22, 2025
by PharmaSources